The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression

• Published in: Life (Basel, Switzerland) Vol. 13; no. 1; p. 197
• Main Authors: Tsochantaridis, Ilias, Roupas, Angelos, Mohlin, Sofie, Pappa, Aglaia, Voulgaridou, Georgia-Persephoni
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-01-2023; MDPI
• Subjects: Aldehyde dehydrogenase; aldehyde dehydrogenase 1B1; aldehyde dehydrogenases; Aldehydes; ALDHs; Apoptosis; Biological markers; Biomarkers; Cancer; Cancer cells; cancer stem cells; Cell division; Cell self-renewal; Chemoresistance; Chemotherapy; Colon cancer; CSCs; Development and progression; Disease; DNA damage; DNA repair; Efflux; Epigenetics; Health aspects; Heterogeneity; Malignancy; Metastasis; Oncology, Experimental; Oxidoreductases; Phenotypes; Phenotypic plasticity; Physiological aspects; Review; Stem cells; Tumors; Greece; aldehyde dehydrogenases; cancer; ALDHs; aldehyde dehydrogenase 1B1; cancer stem cells; CSCs
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life13010197

Cancer is a multifactorial, complex disease exhibiting extraordinary phenotypic plasticity and diversity. One of the greatest challenges in cancer treatment is intratumoral heterogeneity, which obstructs the efficient eradication of the tumor. Tumor heterogeneity is often associated with the presence of cancer stem cells (CSCs), a cancer cell sub-population possessing a panel of stem-like properties, such as a self-renewal ability and multipotency potential. CSCs are associated with enhanced chemoresistance due to the enhanced efflux of chemotherapeutic agents and the existence of powerful antioxidant and DNA damage repair mechanisms. The distinctive characteristics of CSCs make them ideal targets for clinical therapeutic approaches, and the identification of efficient and specific CSCs biomarkers is of utmost importance. Aldehyde dehydrogenases (ALDHs) comprise a wide superfamily of metabolic enzymes that, over the last years, have gained increasing attention due to their association with stem-related features in a wide panel of hematopoietic malignancies and solid cancers. Aldehyde dehydrogenase 1B1 (ALDH1B1) is an isoform that has been characterized as a marker of colon cancer progression, while various studies suggest its importance in additional malignancies. Here, we review the basic concepts related to CSCs and discuss the potential role of ALDH1B1 in cancer development and its contribution to the CSC phenotype.